Adagio Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Adagio Medical Holdings
ADGM Stock   1.01  0.02  2.02%   
Adagio Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Adagio Medical's valuation are provided below:
Gross Profit
-2 M
Market Capitalization
20.9 M
Enterprise Value Revenue
370.2497
Revenue
137 K
Earnings Share
(2.24)
There are over one hundred nineteen available fundamental signals for Adagio Medical Holdings, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Adagio Medical's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Adagio Medical Total Revenue

282,700

Check Adagio Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagio Medical's main balance sheet or income statement drivers, such as Other Operating Expenses of 75.8 M, Total Operating Expenses of 73.4 M or Interest Income of 2.6 K, as well as many indicators such as Price To Sales Ratio of 64.81, Dividend Yield of 0.0 or PTB Ratio of 0.76. Adagio financial statements analysis is a perfect complement when working with Adagio Medical Valuation or Volatility modules.
  
Build AI portfolio with Adagio Stock
Check out the analysis of Adagio Medical Correlation against competitors.

Adagio Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets58.5 M55.7 M11.8 M
Slightly volatile
Short and Long Term Debt Total17.7 M18.7 M6.5 M
Slightly volatile
Other Current Liabilities3.1 M5.5 M1.4 M
Slightly volatile
Total Current Liabilities15.5 M8.9 M5.6 M
Slightly volatile
Accounts Payable1.8 M3.3 M801.3 K
Slightly volatile
Non Current Assets Total27.9 M26.6 M4.9 M
Slightly volatile
Non Currrent Assets Other20.1 K12.6 K33.3 K
Slightly volatile
Common Stock Shares Outstanding12.9 M13.7 M17.6 M
Slightly volatile
Liabilities And Stockholders Equity58.5 M55.7 M11.8 M
Slightly volatile
Other Current Assets2.6 M2.5 M530 K
Slightly volatile
Total Liabilities31.2 M32.8 M25.3 M
Slightly volatile
Total Current Assets30.6 M29.2 M6.9 M
Slightly volatile
Short Term Debt156.2 K164.4 K3.4 M
Slightly volatile
Property Plant And Equipment Net2 M2.5 M1.8 M
Slightly volatile
Cash12.8 M23.7 M17.1 M
Slightly volatile
Cash And Short Term Investments12.8 M23.7 M17.1 M
Slightly volatile
Non Current Liabilities Total17.8 M18.7 M78.7 M
Slightly volatile
Inventory1.8 M3 M883.9 K
Slightly volatile
Other Stockholder Equity109.3 M104.1 M18.6 M
Slightly volatile
Property Plant And Equipment Gross3.8 M5.6 M3 M
Slightly volatile
Accumulated Other Comprehensive Income8559005.6 K
Pretty Stable
Capital Stock1.4 K2.3 K1.2 K
Slightly volatile
Non Current Liabilities Other4.4 M4.2 M718.3 K
Slightly volatile
Common Stock1.4 K2.3 K1.2 K
Slightly volatile
Short and Long Term Debt27 M45.6 M16.2 M
Slightly volatile
Long Term Debt19.4 M18.5 M3.3 M
Slightly volatile
Short Term Investments1.1 M1.2 M1.3 M
Slightly volatile
Intangible Assets5.6 M6.3 M6.8 M
Slightly volatile

Adagio Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses75.8 M72.2 M16.7 M
Slightly volatile
Total Operating Expenses73.4 M69.9 M16.1 M
Slightly volatile
Interest Income2.6 K2.7 K5.1 K
Pretty Stable
Selling General Administrative3.3 M4.3 M5.7 M
Slightly volatile
Total Revenue282.7 K309.4 K270 K
Pretty Stable
Research Development4 M4.2 M13.5 M
Slightly volatile
Cost Of Revenue1.5 M2.2 M1.3 M
Slightly volatile
Reconciled Depreciation499.8 K611.8 K394.3 K
Slightly volatile
Selling And Marketing Expenses5.4 M6.1 M6.7 M
Slightly volatile

Adagio Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation491.7 K738.3 K396.9 K
Slightly volatile
Begin Period Cash Flow17.3 K18.2 K28.1 M
Slightly volatile
Other Cashflows From Financing Activities18.9 M18 M3.7 M
Slightly volatile
Depreciation1.7 M1.6 M572.3 K
Slightly volatile
Capital Expenditures1 M1.9 M1.2 M
Pretty Stable
Total Cash From Financing Activities13 M18 M4.7 M
Slightly volatile
End Period Cash Flow12.8 M23.7 M17.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio64.8168.22533
Slightly volatile
Days Sales Outstanding47.642.7449.7606
Slightly volatile
Stock Based Compensation To Revenue1.241.331.3244
Slightly volatile
Capex To Depreciation1.81.373.0229
Slightly volatile
EV To Sales47.2649.75489
Slightly volatile
Inventory Turnover0.820.872.7545
Slightly volatile
Days Of Inventory On Hand334435212
Slightly volatile
Payables Turnover1.070.781.6341
Slightly volatile
Sales General And Administrative To Revenue12.6714.2615.5614
Slightly volatile
Research And Ddevelopement To Revenue18.8219.8152.006
Slightly volatile
Capex To Revenue2.915.514.3996
Slightly volatile
Cash Per Share1.281.220.9477
Very volatile
Days Payables Outstanding442482302
Slightly volatile
Income Quality0.830.450.8789
Slightly volatile
Intangibles To Total Assets0.340.390.4242
Slightly volatile
Current Ratio2.543.761.0682
Slightly volatile
Receivables Turnover7.378.847.6781
Slightly volatile
Capex Per Share0.10.09760.0688
Slightly volatile
Revenue Per Share0.0160.01590.0157
Slightly volatile
Interest Debt Per Share1.760.90.911
Slightly volatile
Debt To Assets0.370.391.2568
Very volatile
Operating Cycle370478256
Slightly volatile
Days Of Payables Outstanding442482302
Slightly volatile
Ebt Per Ebit0.840.770.9656
Very volatile
Quick Ratio2.423.381.006
Slightly volatile
Cash Ratio2.863.055.6727
Slightly volatile
Days Of Inventory Outstanding334435212
Slightly volatile
Days Of Sales Outstanding47.642.7449.7606
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.141.211.0724
Slightly volatile
Fixed Asset Turnover0.150.140.1533
Slightly volatile
Debt Ratio0.370.391.2568
Very volatile
Price Sales Ratio64.8168.22533
Slightly volatile
Asset Turnover0.00470.0050.0137
Very volatile

Adagio Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap17.4 M18.4 M61.6 M
Slightly volatile
Enterprise Value12.7 M13.4 M91.3 M
Slightly volatile

Adagio Fundamental Market Drivers

About Adagio Medical Financial Statements

Adagio Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Adagio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-1 M-1.1 M
Total Revenue309.4 K282.7 K
Cost Of Revenue2.2 M1.5 M
Stock Based Compensation To Revenue 1.33  1.24 
Sales General And Administrative To Revenue 14.26  12.67 
Research And Ddevelopement To Revenue 19.81  18.82 
Capex To Revenue 5.51  2.91 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(267.11)(280.46)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Adagio Medical Holdings is a strong investment it is important to analyze Adagio Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagio Medical's future performance. For an informed investment choice regarding Adagio Stock, refer to the following important reports:
How To Invest In Adagio
Details
Is Adagio Stock a good investment?
Details
What is Adagio Medical's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Adagio Medical Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Pharmaceuticals sector continue expanding? Could Adagio diversify its offerings? Factors like these will boost the valuation of Adagio Medical. If investors know Adagio will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Adagio Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(2.24)
Revenue Per Share
0.009
Quarterly Revenue Growth
0.756
Return On Assets
(0.24)
Return On Equity
(2.10)
Investors evaluate Adagio Medical Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Adagio Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Adagio Medical's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Adagio Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adagio Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Adagio Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY